Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Feasibility of SH2 Domain Profiling as a Molecular Diagnostic Tool for Patients with Hematological Malignancies
Clinical Trial ( IRB ) #: 01-127-2
Title: Feasibility of SH2 Domain Profiling as a Molecular Diagnostic Tool for Patients with Hematological Malignancies
Principal Investigator: Dr. Kazuya Machida
Description: This study plans to evaluate a new laboratory test called SH2 Domain Profiling, can be used as a diagnostic test in patients with lympho-hematopoietic cancers, and if it can be used to better assess the outlook for patients with certain types of cancers.
Classification:
  Blood - Lymphoma
  Cancer - General
Eligibility Criteria: Check with study contact
How to Contact: Mariola Smialek. Telephone: (860) 679-2996. Email: Smialek@uchc.edu
Enrollment Status/Comments: Enrolling/recruiting. For current recruitment status, please check with study contact.